THY1 and neoplasm: The only existing publication that addressed the expression of CD90/Thy-1 in lymphatic endothelium demonstrated that blockade of CD90/Thy-1 impaired the attachment of tumor cells to lymphatic endothelium in mouse and prevented attachment of mononuclear and polymorph nuclear leukocytes to cultured human lymphatic endothelium [9].